
FibroGen Inc
NASDAQ:FGEN

Intrinsic Value
The intrinsic value of one
FGEN
stock under the Base Case scenario is
92.92
USD.
Compared to the current market price of 5.71 USD,
FibroGen Inc
is
Undervalued by 94%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
FibroGen Inc
Balance Sheet Decomposition
FibroGen Inc
Current Assets | 148.5m |
Cash & Short-Term Investments | 33.6m |
Receivables | 147k |
Other Current Assets | 114.8m |
Non-Current Assets | 16.7m |
Other Non-Current Assets | 16.7m |
Free Cash Flow Analysis
FibroGen Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
FibroGen Inc
Revenue
|
102.8m
USD
|
Cost of Revenue
|
9.9m
USD
|
Gross Profit
|
112.8m
USD
|
Operating Expenses
|
-227.5m
USD
|
Operating Income
|
-114.7m
USD
|
Other Expenses
|
104.7m
USD
|
Net Income
|
-10m
USD
|
FGEN Profitability Score
Profitability Due Diligence
FibroGen Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
FibroGen Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
FGEN Solvency Score
Solvency Due Diligence
FibroGen Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Score
FibroGen Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FGEN Price Targets Summary
FibroGen Inc
According to Wall Street analysts, the average 1-year price target for
FGEN
is 10.2 USD
with a low forecast of 10.1 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for FGEN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?